Good manufacturing practice in low‐ and middle‐income countries: Challenges and solutions for compliance
Abstract Approximately 2 billion people globally have limited access to essential medicines, particularly those living in low‐ and middle‐income countries (LMICs). In addition, there is a higher prevalence of substandard and counterfeit medicines in LMICs, which may cause antimicrobial resistance an...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-03-01
|
| Series: | Public Health Challenges |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/puh2.158 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|